Genes make up the blueprints and outline the process of building every living organism. To ensure that the right genes are ...

A powerful new AI tool called PIONEER is poised to transform precision medicine by enhancing our ability to predict protein ...

Behold the Body. Electron microgram of a Biondi body shows a dense core surrounded by filaments that bind gold-labeled secondary antibody to TMEM239 (black dots). [Courtesy of Ghetti et al., 2024.] ...

Dr. Carolina Gandara, Head of Retina Assay Development at Newcells Biotech, leads internal and external projects within the ...

Alector’s AbbVie-partnered Alzheimer's asset has failed to slow disease progression in a phase 2 study, the latest in a ...

By employing cutting-edge technologies, such as AlphaFold3 and Python-based bioinformatics tools, Brenda bridges computational and experimental techniques to provide new insights into this poorly ...

Arizona wildlife officials have released 10 endangered black-footed ferrets in an attempt to rebuild the population at the ...

Cognition Therapeutics (CGTX) provided an update on a biomarker analysis from the Phase 2 ‘SHINE’ study in mild-to-moderate Alzheimer’s ...

Human proteins and their interactions with other biomolecules, especially other proteins, are the cogs that enable biological processes. Each protein ...

Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced a licensing agreement for its CHO Edge System with RevOpsis Therapeutics ("RevOpsis"), a nex ...

In this new analysis, the Company reported changes in plasma biomarkers that may reflect Alzheimer's disease pathology. The results demonstrated that individuals who entered the study with plasma ...

New therapies could prevent the adjustments in intestinal bacteria that enable them to survive in inflamed regions ...